Status:
COMPLETED
Bioactive Glass in the Treatment of Enamel White Spot Lesions
Lead Sponsor:
Rania Salah
Collaborating Sponsors:
Queen Mary University of London
Conditions:
White Spot Lesion of Tooth
Eligibility:
All Genders
14-26 years
Phase:
PHASE3
Brief Summary
the aim of this study is to evaluate the effectiveness of BiominF® and Novamin® in comparison to Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) in the treatment of enamel white spot lesio...
Eligibility Criteria
Inclusion
- Not less than 1 white spot lesion on the labial surface of teeth in the anterior region with code 2 International Caries Detection and Assessment System II (ICDAS-II) or less
- Absence of any active periodontal disease.
- Written informed consent
Exclusion
- Known hypersensitivity/allergy to study products and/or materials used
- teeth having deep carious lesions or extensive restorations
- Unwillingness to be randomly assigned to 1 of the 3 treatment groups
- Advanced periodontal disease.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04401280
Start Date
June 1 2020
End Date
June 30 2021
Last Update
October 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry
Alexandria, Egypt